Vertex Pharmaceuticals
VRTX
🕒 Price Jul 28, 18:34 ET
The overall grade and 100-point score are Premium-only. The 6-metric analysis below is free.
See Premium →💰 Valuation at a glance
Yahoo FinancePrice ÷ EPS. Lower is cheaper vs earnings. Forward-earnings basis.
Theoretical fair value from PER/PBR and upside (under/overvalued) at a glance. Unlock on Premium.
See Premium →📊 Price trend
Open in Multi-chart →Yahoo Finance📈 Key metrics
Yahoo Finance🏢 Peer comparison
Health CareSide by side with the largest names in the same sector. Green beats the sector median.
| Stock | PER | PBR | ROE | Dividend |
|---|---|---|---|---|
| Vertex PharmaceuticalsCurrent | 29.1× | 6.44× | 21.2% | 0.0% |
| Amgen | 27.4× | 23.09× | 89.1% | 2.6% |
| Gilead Sciences | 18.3× |
🏦 Dividend vs deposit rate
This stock pays no dividend (or has no dividend data), so it isn't directly comparable to a deposit rate. It may be a growth name that relies on price appreciation instead.
As of: U.S. Treasury Par Yield (1Y) · 4.00% (2026-05)
📡 Technical signals
📊 Mixed moving averages · RSI 57 neutral
Above the moving averages means short-term bullish; below means bearish. RSI ≥ 70 is overbought and ≤ 30 is oversold.
🎮 What if you had bought?
If you'd bought Vertex Pharmaceuticals in the past, what would it be worth now? Play with the period and amount. (For reference · not a buy recommendation)
※ Simple close-price math, excluding fees, taxes and dividends. Past returns don’t guarantee future results.
📰 Related news
Source: Naver Finance (KR) · Yahoo Finance (US) · external article links
💼 Financial statements
Yahoo FinanceRecent annual
| Period | Revenue | Op. income | Net income | Op. margin |
|---|---|---|---|---|
| 2025 FY | $12.00B | $4.55B | $3.95B | 37.9% |
| 2024 FY | $11.02B | $-233.4M | $-535.6M | -2.1% |
| 2023 FY | $9.87B | $3.78B | $3.62B | 38.3% |
| 2022 FY | $8.93B | $4.25B | $3.32B | 47.6% |
Quarterly results (last 5 quarters)
📚 Metrics & scoringShow moreCollapse
🔎 Data sources & methodologyShow moreCollapse
Every score is auto-computed from the public data below. No manual adjustment.
| Item | Source | Method · update cadence |
|---|---|---|
| Price · volume · 52W | Yahoo Finance | Stored as-is · hourly intraday |
| Financials (revenue, profit, equity, debt) | Yahoo fundamentalsTimeSeries | Annual + quarterly reported · refreshed over ~1 week |
| Short-term (TTM) score | Computed (quarterly financials) | Sum of last 4 quarters + YoY momentum vs same quarter a year ago · daily |
| PER · PBR | Yahoo reported (US) | Yahoo priceToBook · trailingPE |
| Dividend yield | Yahoo Finance | Annual dividend ÷ price · 0% if none |
| ROE · operating margin · debt ratio |